Skip to main content
Premium Trial:

Request an Annual Quote

Exosome Dx Raises $1.5M

NEW YORK (GenomeWeb) – Exosome Diagnostics has raised about $1.5 million in private financing toward a targeted financing of $2.2 million, it said in a regulatory document filed on Monday. 

The raise is an extension of the Cambridge, Massachusetts-based molecular diagnostic firm's Series B round, which raised $27 million in March 2014, a spokesperson for the firm told GenomeWeb. 

She did not disclose the name of the investors in the round but said that Exosome Dx is moving its lead tests toward commercialization with plans to launch a solid tumor panel liquid biopsy this year. Based on simple blood samples, the test will cover 26 genes and 1,000 associated mutations "in the most significant cancer pathways," including EGFR/MAPK and P13K, she said, adding it will initially be made available to pharmaceutical firms as a clinical development tool. 

The company is also eyeing launches this year of plasma-based liquid biopsy tests for the EML4-ALK and EGFR T790M mutations in non-small cell lung cancer, and a urine-based liquid biopsy test for prostate cancer, the spokesperson said.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.